期刊文献+

碘克沙醇致造影剂肾病 被引量:6

Contrast-induced nephropathy caused by iodixanol
原文传递
导出
摘要 1例85岁女性患者为明确疾病诊断行下肢动脉及冠状动脉造影术,术中使用造影剂碘克沙醇150 ml。造影术前患者血尿素5.8 mmol/L,肌酐105μmol/L,钾4.2 mmol/L,钠134 mmol/L,氯97 mmol/L;造影术后第2天出现反酸、恶心、无尿,血尿素10.9 mmol/L,肌酐125μmol/L,尿蛋白(++);第3天仍旧少尿,血尿素13.0 mmol/L,肌酐170μmol/L,钾3.5 mmol/L,钠128 mmol/L,氯98 mmol/L。考虑为碘克沙醇所致急性肾损伤。给予利尿、血液滤过、纠正电解质紊乱等治疗,患者血肌酐水平逐渐下降,造影术后第16天患者好转出院。 An 85-year-old woman received lower limb arteries and coronary angiography in order to confirm the disease diagnosis. The contrast medium was iodixanol (150 ml ). Laboratory examinations revealed the following levels : blood urea 5.8 mmol/L, serum creatinine (SCr) 105 μmol/L, K +4.2 mmol/L, Na+ 134 mmol/L, and C1- 97 mmol/L before the angiography. On day 2 of angiography, the patient developed acid regurgitation, nausea and anuria, laboratory examinations revealed the following levels: blood urea 10.9 mmol/L, SCr 125 μmol/L, urine protein ( ++ ). On day 3, the patient developed oliguria. Laboratory examinations revealed the following levels: blood urea 13.0 mmol/L, SCr 170μmol/L, K +3.5 mmol/L, Na+ 128 mmol/L, C1- 98 mmol/L. The patient was considered as acute renal injury induced by iodixanol. After the treatments with diuresis, hemofihration, and correction of electrolyte imbalance, her serum creatinine level decreased gradually. Sixteenth days after angiography, the patient was improved and discharged.
作者 蔡然 刘晓蒙
出处 《药物不良反应杂志》 CSCD 2013年第2期93-94,共2页 Adverse Drug Reactions Journal
关键词 碘克沙醇 急性肾损伤 Iodixanol Acute kidney injury
  • 相关文献

参考文献2

二级参考文献37

  • 1Liistro F, Falsini G, Bolognese L. The clinical burden of contrast media induced nephropathy. Ital Heart J, 2003, 4: 668-676.
  • 2Zagler A, Azadpour M, Mercado C, et al. N acetylcysteine and contrast induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J, 2006, 151: 140-145.
  • 3Drager L F, Andrade L, Barros de Toledo J F, et al. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant, 2004, 19: 1803-1807.
  • 4Fishbane S, Durham J H, Marzo K, et al. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol, 2004, 15:251-260.
  • 5Kay J, Chow W H, Chan T M, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA, 2003, 289:553-558.
  • 6Katzberg R W. Contrast medium-induced nephrotoxicity: which pathway? Radiology, 2005, 235: 752-755.
  • 7McCullough P A, Soman S S. Contrast-induced nephropathy. Crit Care Clin, 2005, 21: 261-280.
  • 8Vercellino M,Bezante GP,Balbi M.Contrast medium induced nephropathy:new insights into prevention and risk management.Cardiovasc Hematol Agents Med Chem 2009; 7:166-180.
  • 9Chong E,Poh KK,Shen L,Chai P,Tan HC.Diabetic patients with normal baseline renal function are at increased risk of developing contrast-induced nephropathy post-percutaneous coronary intervention.Singapore Med J 2009; 50:250-254.
  • 10Chen XM,Pan XL.Risk markers for contrast induced nephropathy.China Med Herald (Chin) 2009; 6:217-218.

共引文献26

同被引文献79

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部